Hemogenyx Pharmaceuticals PLC (LSE:HEMO) - Share price


Stock Report

Hemogenyx Pharmaceuticals PLC HEMO

Last Price
GBX6.65

Day Change
-0.40|-5.67%

As of 05/06/2020
17:29:55 BST | GBX
Minimum 15 Minutes Delay.

Last Close7.05p
Day Range6.60 - 7.08
Mkt Cap28.84Mil
52-Wk Range0.95 - 15.25
Yield %-
ISINGB00BYX3WZ24
Volume10,398,395
P/E-
P/SInfinity
P/CF-0.20

Share Price

Total Returns 05/06/2020

 Chg (%)  
More ...
Hemogenyx Pharmaceuticals PLC-10.14 
FTSE 100 TR GBP11.26
 
Financials
201720182019
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-0.84-1.68-1.67
Net Profit-2.36-1.54-1.45
Reported EPS-0.90-0.40-0.40
Balance Sheet
Current Assets1.951.850.55
Non Current Assets0.450.450.50
Total Assets2.402.301.05
Current Liabilities0.260.170.18
Total Liabilities---
Total Equity2.130.96-0.35
Cash Flow
Operating Cash Flow-0.45-1.35-1.20
Net Change in Cash1.80-0.19-1.24
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/02/2020PurchaseMr. Peter Redmond1.80555,55610,000.00
09/07/2019Transfer inDr. Vladislav Sandler0.001,066,6670.00

Company Profile

Hemogenyx Pharmaceuticals PLC is a preclinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies and treatments for blood diseases, like leukemia and lymphoma.

Sector

Biotechnology

Index

Next Event 30/09/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-167.77
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Peter Redmond
Executive Director, Chief Executive OfficerDr. Vladislav Sandler
Non-Executive DirectorMs. Alexis M. Sandler
Executive Director, ChairmanProfessor Sir Marc Feldmann AC FRS MB BS PhD FRCP FRCPath FAA F Med Sci
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.